(Q47706781)

5 February 2018

title

Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma (English)

1 reference

5 February 2018

author

Eusebio Chiefari

1

1 reference

5 February 2018

author name string

D Russo

2

1 reference

5 February 2018

D Giuffrida

3

1 reference

5 February 2018

G A Zampa

4

1 reference

5 February 2018

D Meringolo

5

1 reference

5 February 2018

F Arturi

6

1 reference

5 February 2018

I Chiodini

7

1 reference

5 February 2018

D Bianchi

8

1 reference

5 February 2018

M Attard

9

1 reference

5 February 2018

V Trischitta

10

1 reference

5 February 2018

R Bruno

11

1 reference

5 February 2018

P Giannasio

12

1 reference

5 February 2018

A Pontecorvi

13

1 reference

5 February 2018

S Filetti

14

1 reference

5 February 2018

publication date

1 June 1998

1 reference

5 February 2018

Journal of Endocrinological Investigation

published in

1 reference

5 February 2018

volume

21

1 reference

5 February 2018

issue

6

1 reference

5 February 2018

page(s)

358-364

1 reference

5 February 2018

Genetic aspects of multiple endocrine neoplasia

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03350771

Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. A possible regulatory defect in the differentiation of chromaffin tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350771

Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350771

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350771

Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350771

Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350771

Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350771

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350771

Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence

21 January 2018

1 reference

12 December 2020

A case of metastatic medullary thyroid carcinoma: early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens

1 reference

12 December 2020

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A

1 reference

12 December 2020

Family screening in medullary thyroid carcinoma presenting without a family history

1 reference

12 December 2020

Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains

1 reference

12 December 2020

Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity

1 reference

12 December 2020

Presence of mutations in all three ras genes in human thyroid tumors

1 reference

12 December 2020

Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinoma

1 reference

12 December 2020

RET mutations in exons 13 and 14 of FMTC patients

1 reference

12 December 2020

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

1 reference

12 December 2020

Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03350771

1 reference

5 February 2018

1 reference

5 February 2018